If you have been eagerly anticipating the Novavax vaccine that was approved earlier in February, the wait will be over real soon.
Joint Testing and Vaccination Centre
On Wednesday (4 May), the Ministry of Health (MOH) said that Novavax’s Nuvaxovid COVID-19 vaccine will be offered at Singapore’s first Joint Testing and Vaccination Centre and at 20 Public Health Preparedness Clinics (PHPCs) by the end of May.
The joint testing and vaccination centres will offer both COVID-19 testing and vaccination services in the same place. The first centre will be at the former Bishan Park Secondary School.
“The (centres) will allow us to consolidate our resources, while ensuring testing and vaccination services remain accessible to the public,” MOH added.
MOH also said that it was working to have selected PHPCs offer the Nuvaxovid vaccine, adding that further details will be announced in the coming weeks.
The first shipment of the Nuvaxovid COVID-19 vaccine arrived in Singapore on Wednesday.
Included in Vaccination Programme
On 14 February, the multi-ministry task force accepted the recommendation to include the Nuvaxovid vaccine in the national vaccination programme for people aged 18 years and above, for both COVID-19 primary series and booster vaccination.
The Health Sciences Authority also announced on the same day that it had granted interim authorisation for the vaccine.
Join our Telegram channel for more entertaining and informative articles at https://t.me/goodyfeedsg or download the Goody Feed app here: https://goodyfeed.com/app/
Non-mRNA Vaccine
But what is so unique about Nuvaxovid?
Novavax’s new vaccine is a protein-based vaccine, unlike Pfizer and Moderna vaccines which are mRNA vaccines.
This presents an “acceptable alternative” for those aged 18 and above who are ineligible for mRNA vaccines.
However, the mRNA vaccines are still the preferred vaccines due to their higher efficacy and the stronger immune response generated, according to MOH.
Novavax’s COVID-19 vaccine is engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19. It is also said to be more effective than Sinovac, another option for those ineligible for mRNA vaccines.
“Boosters and vaccinations remain a critical part of our COVID-19 strategy in ensuring our population is well protected against infection and severe illness,” said MOH.
Read Also:
- 8 Facts About Novavax, The Latest Non-mRNA COVID-19 Vaccine That’s Now Approved in S’pore
- Late Actor Aloysius Pang’s Last Movie Will Be Released in Thailand Next Month
- Almost 1 Million People Used the SG-JB Borders Over the Long Weekend
- Former Twelve Cupcakes Owner Daniel Ong Has Started Yet Another Eatery, His 6th So Far
Featured Image: Studio Roux / Shutterstock.com
Here's a summary of the Chocolate Finance saga, simplified so even a non-finance kid can understand:
Read Also:
- Malaysia-Bound Travellers Face 2-Hour Delays at Woodlands Checkpoint as March School Holidays Begin
- Kim Soo-hyun’s Agency Denies Dating Minor Kim Sae-ron, Refutes Financial Pressure Claims Following Actress’s Death
- Man Jumps onto Boon Lay MRT Tracks During Rush Hour to Retrieve Phone as Passengers Activate Emergency Stop
- Two Women Disrupt Shanmugam’s Meet-the-People Session with Confrontational Protests over Gaza
- Luxury Bukit Timah Bungalow Converted to High-Stakes Gambling Den; 12 Northern Chinese Suspects Arrested in Police Raid
- Singapore Airlines and Scoot Ban In-flight Power Bank Usage from April 2025 over Safety Concerns
Advertisements
